ASN
BBIO icon

Advisory Services Network’s BridgeBio Pharma BBIO Stock Holding History

Advisory Services Network’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$743 Buy
+10
New +$725 ﹤0.01% 4360
2025
Q4 		– Sell
-1
Closed -$52 – 2029
2025
Q3 		$52 Buy
+1
New +$49 ﹤0.01% 4461
2020
Q4 		– Sell
-60
Closed -$2.9K – 3303
2020
Q3 		$2K Buy
+60
New +$1.89K ﹤0.01% 3065

Other funds holding BBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisory Services Network's BBIO Position: Q1 2026 in Review

Advisory Services Network opened a new position in BridgeBio Pharma (BBIO) in Q1 2026: 10 shares worth $743. The stake represents ﹤0.01% of the portfolio and ranks #4360 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in BBIO as recently as Q3 2025.

Advisory Services Network first reported a position in BBIO in Q3 2020 and has held it in 3 quarters since. The position peaked at $2K in Q3 2020. 457 funds tracked by Wall St. Rank hold BBIO as of Q1 2026.

  • Advisory Services Network held 10 shares of BridgeBio Pharma worth $743 as of Q1 2026.
  • BridgeBio Pharma was a new Advisory Services Network position in Q1 2026.
  • BridgeBio Pharma made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4360 holding.
  • Advisory Services Network first reported a position in BridgeBio Pharma in Q3 2020 and has held it in 3 quarters since.
  • Advisory Services Network's BridgeBio Pharma position peaked at $2K in Q3 2020.
  • 457 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.